| Title: |
Consensus Recommendations for the Use of Automated Insulin Delivery (AID) Technologies in Clinical Practice |
| Authors: |
Phillip, Moshe; Nimri, Revital; Bergenstal, Richard; Barnard-Kelly, Katharine; Danne, Thomas; Hovorka, Roman; Kovatchev, Boris; Messer, Laurel; Parkin, Christopher; Ambler-Osborn, Louise; Amiel, Stephanie; Bally, Lia; Beck, Roy; Biester, Sarah; Biester, Torben; Blanchette, Julia; Bosi, Emanuele; Boughton, Charlotte; Breton, Marc; Brown, Sue; Buckingham, Bruce; Cai, Albert; Carlson, Anders; Castle, Jessica; Choudhary, Pratik; Close, Kelly; Cobelli, Claudio; Criego, Amy; Davis, Elizabeth; de Beaufort, Carine; de Bock, Martin; Desalvo, Daniel; Devries, J Hans; Dovc, Klemen; Doyle, Francis; Ekhlaspour, Laya; Shvalb, Naama Fisch; Forlenza, Gregory; Gallen, Geraldine; Garg, Satish; Gershenoff, Dana; Gonder-Frederick, Linda; Haidar, Ahmad; Hartnell, Sara; Heinemann, Lutz; Heller, Simon; Hirsch, Irl; Hood, Korey; Isaacs, Diana; Klonoff, David; Kordonouri, Olga; Kowalski, Aaron; Laffel, Lori; Lawton, Julia; Lal, Rayhan; Leelarathna, Lalantha; Maahs, David; Murphy, Helen; Nørgaard, Kirsten; O'Neal, David; Oser, Sean; Oser, Tamara; Renard, Eric; Riddell, Michael; Rodbard, David; Russell, Steven; Schatz, Desmond; Shah, Viral; Sherr, Jennifer; Simonson, Gregg; Wadwa, R Paul; Ward, Candice; Weinzimer, Stuart; Wilmot, Emma; Battelino, Tadej |
| Contributors: |
Tel Aviv University (TAU); University of Cambridge Cambridge, UK (CAM); University of Virginia; Barbara Davis Center for Childhood Diabetes (BDC); University of Colorado Anschutz Medical Campus Aurora; Harvard Medical School Boston (HMS); King‘s College London; Bern University Hospital Berne (Inselspital); University of Utah; Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University Milan, Italie (UniSR); Stanford University; Oregon Health and Science University Portland (OHSU); University of Leicester; Università degli Studi di Padova = University of Padua (Unipd); The University of Western Australia (UWA); Université du Luxembourg = University of Luxembourg = Universität Luxemburg (uni.lu); University of Otago Dunedin, Nouvelle-Zélande; Baylor College of Medicine (BCM); Baylor University; Universiteit van Amsterdam = University of Amsterdam (UvA); University of Ljubljana; Harvard University; University of Colorado Denver; McGill University = Université McGill Montréal, Canada; Cambridge University Hospitals - NHS (CUH); University of Sheffield Sheffield; University of Washington Seattle; The University of Edinburgh; University of Manchester Manchester; University of East Anglia Norwich (UEA); IT University of Copenhagen (ITU); University of Melbourne; Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier); Institut de Génomique Fonctionnelle (IGF); Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM); York University Toronto; Massachusetts General Hospital Boston; University of Florida Gainesville (UF); Yale University New Haven; University of Nottingham, UK (UON) |
| Source: |
ISSN: 0163-769X ; Endocrine reviews ; https://hal.science/hal-03771661 ; Endocrine reviews, 2023, 44 (2), pp.254-280. ⟨10.1210/endrev/bnac022⟩. |
| Publisher Information: |
CCSD; Endocrine Society |
| Publication Year: |
2023 |
| Collection: |
Inserm: HAL (Institut national de la santé et de la recherche médicale) |
| Subject Terms: |
Automated Insulin Delivery; Closed-Loop; Consensus Recommendations; Type 1 Diabetes; [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism; [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology |
| Description: |
International audience ; The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past six years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/36066457; PUBMED: 36066457; PUBMEDCENTRAL: PMC9985411 |
| DOI: |
10.1210/endrev/bnac022 |
| Availability: |
https://hal.science/hal-03771661; https://hal.science/hal-03771661v1/document; https://hal.science/hal-03771661v1/file/bnac022.pdf; https://doi.org/10.1210/endrev/bnac022 |
| Rights: |
https://creativecommons.org/licenses/by-nc-nd/4.0/ ; info:eu-repo/semantics/OpenAccess |
| Accession Number: |
edsbas.BB1C48DA |
| Database: |
BASE |